Polymorphism in Protease and Reverse Transcriptase and Phenotypic Drug Resistance of HIV-1 Recombinant CRF02_AG Isolates From Patients With No Prior Use of Antiretroviral Drugs in Abidjan, Côte d'Ivoire

This publication has 8 references indexed in Scilit:

• Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance
  The Lancet, 2002
• Human Immunodeficiency Virus Type 1 Group M Protease in Cameroon: Genetic Diversity and Protease Inhibitor Mutational Features
  Journal of Clinical Microbiology, 2002
• Primary HIV-1 drug resistance in Abidjan (Côte d'Ivoire): a genotypic and phenotypic study
  AIDS, 2002
• World-wide variation in HIV-1 phenotypic susceptibility in untreated individuals: biologically relevant values for resistance testing
  AIDS, 2001
• High Prevalence of Genotypic and Phenotypic HIV-1 Drug-Resistant Strains Among Patients Receiving Antiretroviral Therapy in Abidjan, Côte d'Ivoire
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
• Reduced Susceptibility of Human Immunodeficiency Virus Type 1 (HIV-1) from Patients with Primary HIV Infection to Nonnucleoside Reverse Transcriptase Inhibitors Is Associated with Variation at Novel Amino Acid Sites
  Journal of Virology, 2000
• Protease sequences from HIV-1 group M subtypes A???H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide
  AIDS, 2000
• Activities of cefepime and five other antibiotics against nosocomial PER-1-type and/or OXA-10-type beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp.
  Journal of Antimicrobial Chemotherapy, 1998